| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 02/13/2014 | US20140045943 Hydroxamic Acid Derivatives, Preparation and Therapeutic Uses Thereof |
| 02/12/2014 | CN103570594A Diarylamine compound and application of diarylamine compound in preparation of anti-malignant tumour medicine |
| 02/12/2014 | CN101985428B O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof |
| 02/06/2014 | WO2014020038A1 Process for preparing spiro[2.5]octane-5,7-dione |
| 02/05/2014 | CN103553968A Cinnamic hydroxamic acid compounds and preparation method thereof |
| 01/30/2014 | US20140031368 Selective hdac inhibitors |
| 01/29/2014 | CN102020588B Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 01/28/2014 | US8637702 Derivatives of N-hydroxybenzamide for treating HIV infections |
| 01/23/2014 | WO2014012964A1 New antifibrinolytic compounds |
| 01/08/2014 | EP2682383A1 Auxin biosynthesis inhibitor |
| 01/08/2014 | CN103502204A Auxin biosynthesis inhibitor |
| 12/27/2013 | WO2013190482A1 Resorcinol derivatives and their cosmetic application |
| 12/25/2013 | EP2208721B1 Histone deacetylase inhibitor, composition and use thereof |
| 12/19/2013 | US20130338251 Surface-modified zirconia nanoparticles |
| 12/18/2013 | EP2672835A2 Sweetness enhancers, sweetener compositions, methods of making the same and consumables containing the same |
| 12/18/2013 | CN101857554B Cinamic compounds and derivatives therefrom for inhibition of histone deacetylase |
| 12/12/2013 | US20130331455 Deacetylase inhibitors and uses thereof |
| 12/11/2013 | CN103435514A Matrix metalloproteinase inhibitor and purpose thereof |
| 12/10/2013 | US8604229 Lipoxin analogs and methods for the treatment of periodontal disease |
| 12/10/2013 | US8604083 Method for the treatment of metabolic disorders |
| 12/05/2013 | WO2013180649A1 Mixed multifunctional metal affinity surfaces for reducing aggregate content in protein preparations field |
| 12/04/2013 | EP2669269A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 12/04/2013 | CN101827811B Histone deacetylase inhibitor, preparation and use thereof |
| 12/03/2013 | CA2599411C Enzyme inhibitors |
| 12/03/2013 | CA2530302C Novel aminobenzophenone compounds |
| 11/27/2013 | EP2665829A1 Compounds and methods for the identification and characterization of hdac interacting compounds |
| 11/20/2013 | CN103393630A Method of inducing terminal differentiation |
| 11/20/2013 | CN102329246B Multiple-target-point tamibarotene derivatives, preparation method and purposes thereof |
| 11/14/2013 | WO2013170030A1 Antibacterial agents |
| 11/13/2013 | EP2662353A2 Antibacterial agents |
| 11/05/2013 | US8575391 5-substituted-2-phenylamino benzamides as MEK inhibitors |
| 10/31/2013 | WO2013159736A1 Monofluoro cyclopropane compound, and preparation method and use thereof |
| 10/30/2013 | CN103373911A Monofluorocyclopropane compounds as well as preparation method and application for same |
| 10/24/2013 | US20130281705 Compounds for the treatment of metabolic disorders |
| 10/23/2013 | CN103356516A Small molecule anti-cancer drug based on mitogen-activated protein kinase kinase (MEK) and histone deacetylase (HDAC) double targets and preparation method of small molecule anti-cancer drug |
| 10/16/2013 | EP2650279A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 10/09/2013 | CN103342665A Compounds having histone deacetylase inhibition activity and preparation method thereof |
| 10/08/2013 | US8552218 Isoxazolines for controlling invertebrate pests |
| 10/08/2013 | US8552062 Methods for the treatment of metabolic disorders such as diabetes |
| 10/08/2013 | CA2473938C Human adam-10 inhibitors |
| 09/25/2013 | CN103319371A Preparation method and application of N-substituted hydroxamic acid compound |
| 09/19/2013 | US20130244944 Synthetic Ion Channels |
| 09/18/2013 | EP2638009A2 Fluorinated hdac inhibitors and uses thereof |
| 09/18/2013 | EP2638006A1 Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
| 09/11/2013 | CN103298780A Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
| 09/04/2013 | CN103275067A Inhibitors of histone deacetylase |
| 08/15/2013 | WO2013119751A1 Process for preparing carboxamidine compounds |
| 08/15/2013 | US20130211130 Process for preparing carboxamidine compounds |
| 08/14/2013 | CN103242192A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 08/13/2013 | US8507726 Photoinitiator mixtures |
| 08/13/2013 | US8507725 Oxime ester photoinitiators |
| 08/08/2013 | US20130203847 Pharmaceutical Formulation for Histone Deacetylase Inhibitors |
| 07/24/2013 | CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 07/18/2013 | WO2013105053A1 Compounds having antibacterial activity, process for their preparation and pharmaceutical compositions comprising them |
| 07/17/2013 | EP2613775A1 Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/17/2013 | CN103204963A Synthetic method of hydroxamic acid polymer |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486934 Oxadiazine-substituted arylamides |
| 07/10/2013 | CN103200936A Novel n-hydroxy-benzamides for the treatment of cancer |
| 07/02/2013 | US8476315 N-hydroxy C29-amide derivatives of oleandrane |
| 06/27/2013 | WO2013094498A1 METHOD FOR RACEMIZING α-SUBSTITUTED-β-AMINO ACID ESTER |
| 06/27/2013 | WO2013091082A1 Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer |
| 06/27/2013 | US20130165520 Hybrid Molecule Having Mixed Retinoic Acid Receptor Agonism and Histone Deacetylase Inhibitory Properties |
| 06/26/2013 | CN103180291A Alkoxyimino derivative and pest control agent |
| 06/26/2013 | CN103172540A Phenylglycine histone deacetylase inhibitor as well as preparation method and applications thereof |
| 06/19/2013 | CN103159646A Hydroxamic acid compound, and preparation method and application thereof |
| 06/18/2013 | US8466130 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 06/06/2013 | WO2013080479A1 Glyoxime derivative and pesticide |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 05/22/2013 | EP2594553A1 Alkoxyimino derivative and pest control agent |
| 05/15/2013 | CN101372470B Oxime ether methoxy acrylate compound having disinsection and sterilization activity |
| 05/09/2013 | US20130116318 Enzyme Inhibitors |
| 05/08/2013 | CN103086922A N-alkoxy-4-pentenamide compound and preparation method thereof |
| 05/08/2013 | CN103086921A 2-(4-aryloxyphenoxy)alkylamide and application thereof |
| 05/07/2013 | CA2491131C Novel compounds as histone deacetylase inhibitors |
| 05/02/2013 | WO2013060818A1 Novel process |
| 05/01/2013 | CN103073451A Histone deacetylase inhibitor |
| 04/25/2013 | WO2013057186A1 Photolabile linker for the synthesis of hydroxamic acids |
| 04/24/2013 | EP2582832A1 Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disorders |
| 04/24/2013 | CN101265226B Compounds and methods for delivery of prostacyclin analogs |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/16/2013 | US8420698 Histone deacetylase inhibitors |
| 04/04/2013 | WO2013045734A1 Compounds having antileishmanial activity |
| 04/03/2013 | CN103012209A Diaryl propionyl hydroxamic compound and preparation method and use thereof |
| 04/03/2013 | CN103012208A Urea enzyme inhibitor phenyl benzyl propionyl hydroxamic acid and preparation method and use thereof |
| 04/03/2013 | CN103012207A Diaryl propionyl-N-methyl hydroxamic acid type urease inhibitor and synthesis and application thereof |
| 03/27/2013 | EP2573069A2 Inhibitors of histone deacetylase and prodrugs thereof |
| 03/27/2013 | EP2571352A1 Selective hdac inhibitors |
| 03/27/2013 | CN103003233A Novel hydroxamic acid derivative |
| 03/27/2013 | CN102993052A Aryl propionyl hydroxamic acid urease inhibitor, and synthesis and use thereof |
| 03/27/2013 | CN102993051A Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 03/21/2013 | WO2013039947A1 Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide |
| 03/21/2013 | US20130072677 Novel hydroxamic acid derivative |
| 03/20/2013 | CN102976975A Aryl propionyl-N-methyl hydroxamic acid urease inhibitor, synthesis and application thereof |
| 03/20/2013 | CN102976974A Phenyl benzyl propionyl-N-methyloxyxamic urease inhibitor and synthesis and use thereof |
| 03/19/2013 | CA2538960C Cinnamoyl compound and use of the same |
| 03/14/2013 | WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease |
| 03/14/2013 | US20130065963 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 03/12/2013 | US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |